ROP INT DEPEND UNIT NOC ULT GDE C/8 NIFEDIPINO 10.00 MG PRINCIPIO ACTIVO: OXELADINA - BROMHEXINA

Description

PRINCIPIO ACTIVO: OXELADINA - BROMHEXINA

INLYTA® 5 mg es un medicamento antineoplásico que contiene Axitinib

Takeda Pharmaceuticals America

Contenido expresado como 25 mg de activo equivalente (AE)

FORMA FARMACÉUTICA: LOCIÓN

ROP INT DEPEND UNIT NOC ULT GDE C/8 NIFEDIPINO 10.00 MG PRINCIPIO ACTIVO: OXELADINA - BROMHEXINA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy